Skip to main content
Skip to main content
Back to Grand Rounds
Grand RoundsWeekly Evidence Brief

Pediatrics

Edition

30-Second Takeaway

  • Phoenix Sepsis Criteria outperform IPSCC for early sepsis identification; PELOD-2 remains the strongest mortality predictor in PICU.
  • Influenza antivirals remain underused in hospitalized children, with further declines after COVID-19 despite unchanged indications.
  • Home-based transcutaneous bilirubin screening detects more treatable jaundice and appears cost-saving versus visual inspection alone.

Week ending January 17, 2026

Fast takes for pediatricians: sepsis scoring, influenza antivirals, jaundice screening, behavior care, imaging equity, VLBW feeds, Hodgkin PET, long-read GS, and RSV modeling

Phoenix Sepsis Criteria and PELOD-2 refine early PICU sepsis risk stratification

CRITICAL CARE MEDICINEJan 14, 2026

In 687 PICU patients with suspected infection, Phoenix Sepsis Criteria (PSC) showed higher sensitivity and positive predictive value for mortality than IPSCC criteria on days 1 and 2. Day 1 PSC sensitivity for mortality was 96.4% versus 82.1% for IPSCC, with modestly higher positive predictive value. By day 2, PSC sensitivity reached 100.0%, compared with 75.0% for IPSCC, again with similar or better positive predictive value. For mortality prognostication, PELOD-2 had the highest precision–recall performance on both days and outperformed IPSCC Severe Sepsis and Phoenix-based scores.

Antiviral treatment for hospitalized pediatric influenza declined after the COVID-19 pandemic

PEDIATRICSJan 14, 2026

Across seven US sites, 1560 children hospitalized with influenza had suboptimal antiviral use both before and after the COVID-19 pandemic. Prepandemic antiviral use ranged from 48.3% to 56.8%, falling to 38.1% in 2021–2022 and 46.1% in 2022–2023. Overall antiviral use was 23% lower in the late pandemic versus prepandemic period (incidence proportion ratio 0.77; 95% CI, 0.68–0.87). During the late pandemic, treatment was more likely with underlying conditions, current-season influenza vaccination, clinical influenza testing, ICU admission, and at certain sites.

Universal home TCB screening improves detection of treatable neonatal hyperbilirubinemia

JAMA NETWORK OPENJan 12, 2026

In 2314 near-term and term neonates receiving home midwifery care, universal transcutaneous bilirubin (TCB) screening detected more treatment-threshold hyperbilirubinemia than visual inspection alone. Of 78 infants exceeding treatment thresholds, 28 were identified only through TCB, representing many cases missed by visual assessment. TCB screening increased heel pricks versus visual inspection (244 vs 142), with most missed cases attributable to user misinterpretation or laboratory bias. Selective TCB only in visibly jaundiced infants reduced extra heel pricks without losing diagnostic performance.

Parent-focused and multicomponent psychosocial programs reduce disruptive behavior in children

PEDIATRICSJan 13, 2026

This meta-analysis included 64 randomized trials of psychosocial treatments for disruptive behavior in preschool and school-aged children, plus 20 additional adolescent trials. In preschoolers, parent-only and multicomponent interventions both produced moderate to large reductions in disruptive behavior immediately posttreatment. In school-aged children, both intervention types also reduced disruptive behavior, with somewhat smaller, but still meaningful, effect sizes. Longer-term follow-up effects were inconsistent, and adolescent studies were too heterogeneous for pooled estimates.

References

Numbered in order of appearance. Click any reference to view details.

Additional Reads

Optional additional studies from this edition.

Edition context

Clinical signal

  • Modernized sepsis and organ dysfunction scores can materially improve PICU risk stratification and prognostication beyond legacy IPSCC criteria.
  • Practice gaps persist in everyday pediatrics, including antiviral underuse, variable jaundice screening, and potential inequities in infant head CT use.
  • Behavioral, lactation, and nutrition-focused interventions remain high-yield, low-harm levers for neurodevelopmental and neuroprotective outcomes.